A Study to Investigate the Effect of JNJ-64565111 on Cardiac Repolarization (Corrected QT Interval) Compared With Placebo in Healthy Adults: a Thorough ECG Study Employing Placebo, JNJ-64565111, and a Positive Control (Moxifloxacin)
Clinical trial NCT03606057 · COMPLETED
Trial details
- NCT number
- NCT03606057
- Sponsor
- Janssen Research & Development, LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-07-13
- Primary completion
- 2019-02-08
- Enrollment
- 188
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.